Glabridin.
Research-backed fatty acid with potential health benefits. Helps even out skin tone by blocking the enzyme that makes dark spots. Some early research suggests it may also help reduce visceral fat and support healthy blood sugar.
Reviewed March 2026
- Category
- Fatty acid
What Glabridin is, and what it does.
- Does it work
- Maybe. If you're targeting hyperpigmentation or looking for an add-on for metabolic health, it's worth a look. The evidence isn't a slam dunk yet.
- How much to take
- Studies use a wide range. 100-300mg daily is a common area for research on metabolic support. More is not necessarily better here.
- Time to feel it
- Skin tone changes are gradual, and studies of tyrosinase-directed actives read out at eight to twelve weeks. Metabolic measures show on a blood panel rather than in sensation.
- The first dose
- Nothing. Absolutely zero. Don't expect to feel anything.
- With regular use
- After 2-3 months, you might see a gradual fading of dark spots. Metabolic changes would need a blood test to confirm. It's subtle.
- How well tolerated
- Considered well tolerated at standard doses. Make sure it's from deglycyrrhizinated licorice (DGL) to avoid blood pressure issues. Not much data for pregnancy or breastfeeding.
- How it feels
- You don't 'feel' it. It works on a cellular level. Any visible changes to skin or body composition will be slow and gradual.
- The overlooked benefit
- Glabridin is not glycyrrhizin. It is the oil-soluble part of licorice root and carries none of the structure behind licorice's effect on blood pressure.
30 to 60mg a day is where Glabridin works.
Source: Ito et al. J Nutr Sci Vitaminol 2009; licorice extract studies
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Glabridin is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- an even skin tone through melanin synthesisIn vitro study
- antioxidant activity within cell membranesIn vitro study
- healthy body compositionRandomised trial
- glucose metabolism already in the normal rangeAnimal study
- weak binding at oestrogen receptorsIn vitro study
Questions people ask about Glabridin.
- Is this the same as eating licorice candy?
- Nope. Candy has sugar, flavor, and very little glabridin. Plus, most licorice candy contains glycyrrhizin, which can raise blood pressure.
- Will it lighten my overall skin color?
- Unlikely. It targets excess melanin production in dark spots, not your baseline skin tone. Think 'evening out', not 'whitening'.
- How long until I see results?
- Be patient. At least 8-12 weeks for any visible skin changes. Metabolic effects would take just as long to show up on a lab test.
- Can I just use it on my skin directly?
- Yes, it's common in serums for hyperpigmentation. Taking it orally works from the inside out, while topical is more direct for skin spots.
- What does 'DGL' on the label mean?
- Deglycyrrhizinated Licorice. It means they removed glycyrrhizin, the compound that can spike blood pressure. It's the safer choice for a supplement.
- Does it really help with weight loss?
- Maybe, specifically with visceral fat. But it's not a weight loss pill. Diet and exercise are doing 99% of the work.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Glabridin damps tyrosinase activity inside the melanocyte, while niacinamide acts one step later by slowing transfer of pigment granules to surrounding keratinocytes. Addressing production and hand-off separately is why the two are routinely formulated together for evenness of skin tone.
Both slow tyrosinase, and ascorbic acid additionally holds oxidised melanin intermediates in their reduced, lighter state rather than letting them polymerise. Vitamin C also blunts the oxidative stress that prompts melanocytes to raise pigment output.
Azelaic acid is a competitive tyrosinase inhibitor reported to act preferentially on more active melanocytes, while glabridin damps the same enzyme without azelaic acid's keratolytic effect. The two therefore reach the pigment pathway by different routes within one formula.
Glabridin is the isoflavan isolated from licorice root, so a formula carrying both is stacking the same molecule twice, once standardised and once as whole extract. Total glabridin load should be read across both inputs rather than from the isolate alone.
Glabridin lowers tyrosinase activity inside the melanocyte while retinoids speed keratinocyte turnover and slow melanosome transfer outward. The two act at different steps of normal pigment handling.
Salicylic acid is lipophilic and loosens corneocyte cohesion along the sebaceous route, the same route a lipophilic isoflavan takes into the epidermis. Loosening that path is the stated reason brands sequence the two.
Resveratrol is another plant polyphenol that binds the copper centre of tyrosinase and lowers its turnover. Two competitive inhibitors of the same enzyme give more inhibition than either alone at the same total polyphenol load.
Glabridin is poorly water soluble, so it needs an oil phase to stay dissolved and to partition into skin lipids. Squalane is the usual carrier because it matches sebum closely and does not oxidise readily.
Repeated use of exfoliating and brightening actives thins the intercellular lipid mortar that holds water in the stratum corneum. Supplying the ceramide fraction back replaces that specific lipid class.
Bakuchiol shifts the same retinoid-responsive genes as retinol but tolerates a wider pH and is also lipophilic, so it shares an oil phase with glabridin. The pairing gives turnover plus tyrosinase inhibition in one base.
Catechins quench the reactive oxygen species that switch on melanogenic signalling upstream of tyrosinase, a step earlier than glabridin acts. Working upstream and at the enzyme covers two points of the same pathway.
Glabridin is a lipophilic isoflavan that partitions into lipid phases, the same compartment tocopherol works in. Both scavenge lipid-phase radicals, and tocopherol is regenerated by water-phase reductants. The pairing is standard antioxidant formulation logic rather than a measured combination effect.
Glutathione is the main intracellular thiol buffer and appears alongside glabridin in oxidative-stress laboratory work. Glabridin acts in the lipid phase while glutathione works in the cytosol, so they cover different compartments. Evidence here is cell-based, not human outcome data.
An animal study assessed glabridin together with gymnemic acid on eye tissue structural measures in rats with high blood sugar. That is a preclinical combination, in a single model, on tissue measures. It grounds the pairing as studied, not as demonstrated in people.
Glabridin is poorly water soluble and dissolves readily in medium-chain triglycerides, which is why oil-dispersed and encapsulated preparations exist. The vehicle governs how much material is actually presented for absorption or for topical delivery. This is a formulation determinant, not an added biological effect.
Phospholipid emulsifiers form the liposomal and micellar systems used to disperse lipophilic flavonoids in aqueous formulations. Without one, a glabridin-standardised extract separates out. Widely used in both oral and topical products for exactly this reason.
Astaxanthin spans the lipid bilayer and quenches singlet oxygen, a different radical species from those flavonoids handle most efficiently. Both are lipophilic, so they formulate into the same oil phase. The combination is common in skin-directed products and lightly studied as a combination.
Quercetin and glabridin are both polyphenolic radical scavengers with reported effects on the same oxidative-stress readouts in cell work. Quercetin is more water compatible, glabridin more lipophilic. Any additive effect is inferred from shared chemistry, not measured together.
Pine bark proanthocyanidins are used in skin-tone formulations for their antioxidant profile. Glabridin is used alongside them for its own laboratory-characterised activity. The pairing is a formulation convention with a plausible shared rationale.
Grape seed proanthocyanidins scavenge reactive oxygen species in the aqueous phase, while glabridin partitions into lipid. Both appear in the same skin-directed blends. No combination measurement is cited here.
Sulforaphane is a well-characterised inducer of the Nrf2 antioxidant response element pathway, and glabridin has been reported to influence oxidative-stress and inflammatory readouts in cell and animal models. Both act on endogenous defence rather than by direct scavenging alone. The evidence is preclinical on both sides.
Silymarin is a flavonolignan complex with its own antioxidant profile and similar poor water solubility. The two share formulation problems and formulation solutions. Combined data is absent; the pairing is a rationale, not a result.
Piperine inhibits several intestinal and hepatic metabolising enzymes, which raises circulating levels of some poorly bioavailable polyphenols. Whether that applies to glabridin specifically has not been established. Flagged because the same inhibition can raise levels of other things in a stack too.
Hyaluronic acid holds water in the outer skin layers and is used as the aqueous partner to lipophilic actives in topical systems. It does not interact chemically with glabridin. It is a delivery pairing, listed as such.
Zinc supports normal skin cell turnover and protein synthesis through its role in a wide set of enzymes. Glabridin acts on oxidative and pigmentation-related readouts in laboratory models. They address different layers of the same tissue and have not been studied together.
Nothing specific on file for Glabridin. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Glabridin actually does.
Glabridin is a prenylated isoflavan, one of the flavonoid family, and it is the principal lipophilic constituent of the hydrophobic fraction of Glycyrrhiza glabra root.
Glabridin is chemically distinct from glycyrrhizin, the sweet triterpene saponin of the same root. Glycyrrhizin is water soluble and drives the mineralocorticoid effects associated with licorice; glabridin is lipophilic and carries none of that structure.
Glabridin inhibits tyrosinase activity in cell-free and cultured cell systems, the rate-limiting enzyme step in melanin synthesis, which is the basis for its use in products aimed at supporting an even skin tone.
As a phenolic compound glabridin donates hydrogen atoms to lipid radicals, terminating chain propagation within membranes; its lipophilicity is what places it in that compartment.
The forms it comes in.
The essence, in one line each.
- In 84 adults carrying extra body weight, eight weeks of licorice flavonoid oil, whose most abundant flavonoid is glabridin, lowered total body fat mass at all three doses, and the 900 mg daily dose also lowered visceral fat area, body weight, BMI and LDL cholesterol from baseline.Randomised trial. Tominaga et al., 2009 (Obesity Research and Clinical Practice). PMID 24345587 ↗
- In healthy adults, glabridin from licorice flavonoid oil peaked in blood about 4 hours after a dose and cleared with a half-life near 10 hours, reaching steady levels within 2 weeks at 300 to 1200 mg daily, with no clinically notable changes in blood counts or blood chemistry over 4 weeks.Randomised trial. Aoki et al., 2007 (Journal of the American College of Nutrition). PMID 17634165 ↗
- In a small pilot in healthy adults, six months of a glycyrrhizin-free licorice root extract supplying 60 mg glabridin daily lowered measured oxidative stress and LDL oxidation by about 20 percent.Randomised trial. Carmeli et al., 2008 (Journal of Basic and Clinical Physiology and Pharmacology). PMID 19024795 ↗
- Licorice flavonoid oil, the glabridin-carrying fraction, was tested against placebo on body composition and blood lipid measures, with only small differences seen between groups.Randomised trial. Bell et al., 2011 (Lipids in health and disease). PMID 21310080 ↗
- The review of topical cosmeceuticals places glabridin among the licorice-derived agents with human data for evening skin tone and reducing the appearance of pigment, at generally modest effect sizes.Systematic review. Chan et al., 2024 (Skin research and technology). PMID 39233460 ↗
- Glabridin reduced oxidative stress and inflammatory markers in a bovine intestinal cell line and in a mouse model; these are markers in animal and cell systems, not human outcomes.Animal study. An et al., 2025 (Iranian Journal of Veterinary Research). PMID 42491765 ↗
- The authors mapped the branched biosynthetic network that produces glabridin in licorice, identifying the enzymatic steps involved; this characterises how the plant makes the molecule.In vitro study. Zhang et al., 2026 (Nature Communications). PMID 41620399 ↗
- Key enzymes in the glabridin biosynthesis pathway were identified and used to produce the compound in licorice hairy root culture, an alternative production route to field-grown root.In vitro study. Jiang et al., 2026 (Molecular Horticulture). PMID 41782076 ↗
- Methyl jasmonate elicitation changed flavonoid biosynthesis gene expression in Glycyrrhiza glabra hairy roots, with glabridin named among the pathway products; relevant to yield in cultivation rather than to human effects.In vitro study. Zhu et al., 2025 (Genes). PMID 41300839 ↗
These are the studies our verdict leans on, chosen from the 458 we read for Glabridin. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.